Articles
Due to the copyrights of the publishing party, some of the links lead to websites that require payment for the article. However, the article’s abstract is given in full.
Drug treatment of congenital CMV:
Revised Protocol for Secondary Prevention of Congenital Cytomegalovirus Infection With Valaciclovir Following Infection in Early Pregnancy
Jacob Amir, G. Chodick, and Joseph Pardo
Clinical Infect Diseases, May 9, 2023
Valaciclovir to prevent vertical transmission of cytomegalovirus after maternal primary infection during pregnancy: a randomised, double-blind, placebo-controlled trial
Keren Shahar-Nissan, ,Joseph Pardo, Orit Peled, Irit Krause, Efraim Bilavsky, Arnon Wiznitzer, et al.
VOLUME 396, ISSUE 10253, P779-785, SEPTEMBER 12, 2020- The Lancet
Hematologic Adverse Events Associated with Prolonged Valganciclovir Treatment in Congenital Cytomegalovirus Infection
Bilavsky Efraim, Osovsky Micky, Amir Jacob, Yarden-Bilavsky Havatzelet, Pardo Joseph, Yacobovich Joanne, Ziv Liron
The Pediatric Infectious Disease Journal April 19,2018- Volume Publish Ahead of Print Issue
Doi: 10.1097/inf.0000000000002079
Valganciclovir Is Beneficial in Children with Congenital Cytomegalovirus and Isolated Hearing Loss
.Yehonatan Pasternak, Liron Ziv, Joseph Attias, Jacob Amir, Efraim Bilavsky
The Journal of Pediatrics 2018
Valganciclovir for symptomatic congenital cytomegalovirus disease
Kimberlin DW, Jester PM, Sánchez PJ, et al
. N Engl J Med. 2015;372:933-943
Treatment of Late-Onset Hearing Loss in Infants With Congenital Cytomegalovirus Infection (Requires payment)
Jacob Amir, MD1,2, Joseph Attias, DSc1, and Joseph Pardo, MD2,3
Clin Pediatr (Phila). 2014 May;53(5):444-8. doi: 10.1177/0009922813510204. Epub 2013 Nov 25
In utero treatment of congenital cytomegalovirus infection with valacyclovir
in a multicenter, open-label, phase II study
Leruez-Ville M1, Ghout I2, Bussières L3, Stirnemann J4, Magny JF5, Couderc S6, Salomon LJ4, Guilleminot T1, Aegerter P2, Benoist G7, Winer N8, Picone O9, Jacquemard F10, Ville Y11
Am J Obstet Gynecol. 2016 Oct;215(4):462.e1-462.e10. doi: 10.1016/j.ajog.2016.04.003. Epub 2016 Apr 13
The information on the site is updated as of its upload date. It only intends to provide information and is does not constitute and/or does not claim to a substitute for medical advice, medical opinion, exhaustive research on the subject or consultation with a healthcare specialist. Use of the website is the sole responsibility of its users and it does not replace the responsibility of the users to receive individual consultation by a qualified healthcare party, on a case by case basis. The website’s administration requests to stress that anyone searching for information on CMV must seek appropriate healthcare consultation.
Welcome to www.cmv.co.il – the website for the Israeli Association for CMV Pregnancy.
Users of the site must read these terms carefully before using the site, as using the site indicates the user’s consent to the terms.
The information on the site is updated as of its upload date. It only intends to provide information and is does not constitute and/or does not claim to a substitute for medical advice, medical opinion, exhaustive research on the subject or consultation with a healthcare specialist.
Use of the website is the sole responsibility of its users and it does not replace the responsibility of the users to receive individual consultation by a qualified healthcare party, on an individual case basis.
The website’s administration would like to stress that anyone seeking information on CMV must refer to appropriate healthcare consultation.
Users will have no claim, complaint or demand against the Association concerning the information presented on or through this site, its accuracy, reliability, completeness, relevancy, and the frequency of its publication.
Use of the information on the site and reliance on it will be the sole and complete responsibility of the users.
The Association reserves the right to update, modify, add or remove anything, without prior or late notice, at its sole discretion.
All copyright and intellectual property on the site belong to the Association, unless explicitly stated that the copyright of the protected information, or any part thereof, belongs to another party.
No part of the protected information may be copied, reproduced, distributed, marketed, publicly distributed, translated or disclosed to any third party without receiving the explicit written consent of the Association in advance.
I ratify my consent